These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 27920066

  • 1. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT.
    Hum Reprod Update; 2017 Mar 01; 23(2):232-254. PubMed ID: 27920066
    [Abstract] [Full Text] [Related]

  • 2. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M.
    Arch Gynecol Obstet; 2022 Aug 01; 306(2):407-421. PubMed ID: 35001185
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F, Dong D, Du H, Guo Y, Su X, Wang Z, Xie X, Wang M, Zhang H, Cao X, He X.
    Comput Methods Programs Biomed; 2022 Jun 01; 221():106906. PubMed ID: 35671602
    [Abstract] [Full Text] [Related]

  • 4. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A, Raffone A, Saccone G, Mascolo M, D'Alessandro P, Arduino B, Mollo A, Insabato L, Zullo F.
    APMIS; 2019 Nov 01; 127(11):699-709. PubMed ID: 31403731
    [Abstract] [Full Text] [Related]

  • 5. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
    Lacey JV, Mutter GL, Nucci MR, Ronnett BM, Ioffe OB, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME.
    Cancer; 2008 Oct 15; 113(8):2073-81. PubMed ID: 18720479
    [Abstract] [Full Text] [Related]

  • 6. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A, Travaglino A, Saccone G, Mascolo M, Insabato L, Mollo A, De Placido G, Zullo F.
    Acta Obstet Gynecol Scand; 2019 Mar 15; 98(3):287-299. PubMed ID: 30511741
    [Abstract] [Full Text] [Related]

  • 7. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
    Kender Erturk N, Basaran D, Salman C.
    J Obstet Gynaecol; 2022 May 15; 42(4):692-695. PubMed ID: 34415826
    [Abstract] [Full Text] [Related]

  • 8. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
    Raffone A, Travaglino A, Saccone G, Viggiani M, Giampaolino P, Insabato L, Mollo A, De Placido G, Zullo F.
    Arch Gynecol Obstet; 2019 Jun 15; 299(6):1511-1524. PubMed ID: 30915635
    [Abstract] [Full Text] [Related]

  • 9. Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding.
    Giannella L, Cerami LB, Setti T, Bergamini E, Boselli F.
    Biomed Res Int; 2019 Jun 15; 2019():8598152. PubMed ID: 31011581
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
    Raffone A, Travaglino A, Saccone G, Cieri M, Mascolo M, Mollo A, Insabato L, Zullo F.
    APMIS; 2019 Sep 15; 127(9):597-606. PubMed ID: 31237034
    [Abstract] [Full Text] [Related]

  • 11. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
    Travaglino A, Raffone A, Saccone G, Mollo A, De Placido G, Mascolo M, Insabato L, Zullo F.
    APMIS; 2019 Jun 15; 127(6):427-434. PubMed ID: 30802329
    [Abstract] [Full Text] [Related]

  • 12. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
    Travaglino A, Raffone A, Saccone G, D'Alessandro P, Arduino B, de Placido G, Mascolo M, Insabato L, Zullo F.
    Arch Gynecol Obstet; 2019 Nov 15; 300(5):1147-1154. PubMed ID: 31531779
    [Abstract] [Full Text] [Related]

  • 13. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S.
    Pathologe; 2011 Nov 15; 32 Suppl 2():255-64. PubMed ID: 22033684
    [Abstract] [Full Text] [Related]

  • 14. Management of endometrial precancers.
    Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL, Society of Gynecologic Oncology Clinical Practice Committee.
    Obstet Gynecol; 2012 Nov 15; 120(5):1160-75. PubMed ID: 23090535
    [Abstract] [Full Text] [Related]

  • 15. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
    Kalkan HE, Akman L, Serin G, Terek MC, Zekioglu O, Ozsaran AA.
    Histol Histopathol; 2024 May 15; 39(5):565-571. PubMed ID: 37503793
    [Abstract] [Full Text] [Related]

  • 16. Endometrial hyperplasia and the risk of progression to carcinoma.
    Lacey JV, Chia VM.
    Maturitas; 2009 May 20; 63(1):39-44. PubMed ID: 19285814
    [Abstract] [Full Text] [Related]

  • 17. Benign and Premalignant Lesions of the Endometrium.
    Mallinger WD, Quick CM.
    Surg Pathol Clin; 2019 Jun 20; 12(2):315-328. PubMed ID: 31097106
    [Abstract] [Full Text] [Related]

  • 18. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
    Francz M.
    Magy Onkol; 2008 Mar 20; 52(1):35-40. PubMed ID: 18403295
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.